Journal Basic Info
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.Major Scope
- Melanoma/Skin Cancer
- Immunology
- Endoscopy Methods
- Head and Neck Oncology
- Radiation Oncology
- Chemoprevention
- Gastrointestinal Cancer
- Surgical Oncology
Welcome
Clinics in Oncology™ (Impact Factor: 2.709*) and (ISSN 2474-1663) devoted exclusively to the publication of high-quality manuscripts in the fields of cancer research. Journal supports the publication of original material involving the complete solution of significant problems in the above disciplines. Journal also encourages the publication of timely and thorough survey articles on current trends and future forecasts in cancer research. The paramount objective of Clinics in Oncology™ is to showcase and promote distinguished research in the field of Oncology, to help advance the development of this field. The Journal covers all aspects of the clinical management of cancer patients and its authors are drawn from leading international centers.
Clinics in Oncology™ (Impact Factor: 2.709*) encircles a wide range of informative and advanced articles that contribute significantly to the field of oncology. The journal's scope covers various aspects of oncology research, including basic science, translational research, clinical studies, and reviews.
NLM ID
Recently Published Articles
Bowen's Disease and Eccrine Porocarcinoma Developed after Herniorrhaphy: A Case Report and Literatures Review
Chea K, Huang Q, Chena B and Hua X
Abstract PDF Full Text Case Report | Open Access
Citation: Clin Oncol. 2023;8(1):2014. DOI: 10.25107/2474-1663.2014
Dual TKI Therapy in Acquired ALK Gene Fusion as Mechanism of Resistance to Osimertinib in EGFR-Mutant Advanced NSCLC
Portugal GM, Sousa AC2 and Alves P
Abstract PDF Full Text Case Report | Open Access
Citation: Clin Oncol. 2023;8(1):2013. DOI: 10.25107/2474-1663.2013
Network Pharmacology and Molecular Docking Strategy Reveal the Mechanism of Tripterygium wilfordii in Treating Castration-Resistant Prostate Cancer
Yang X, Yimamu Y, Xiao W, Jiang S and Pan J
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2023;8(1):2011. DOI: 10.25107/2474-1663.2011
A Cuproptosis-Related lncRNAs Risk Model to Predict Prognosis and Immune Characteristics in Breast Cancer
Xu XY, Song YH, Liu XQ and Lin XY
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2023;8(1):2010. DOI: 10.25107/2474-1663.2010
NDFIP1 as a Diagnostic Biomarker, Correlated with Immune Infiltrates in Breast Cancer
Xu X, Yin K, Zhang Y and Lin X
Abstract PDF Full Text Research Article | Open Access
Citation: Clin Oncol. 2023;8(1):2009. DOI: 10.25107/2474-1663.2009
Role of Pelvic Lymph Node Dissection during Radical Cystectomy
Kwon WA
Abstract PDF Full Text Review Article | Open Access
Citation: Clin Oncol. 2023;8(1):2008. DOI: 10.25107/2474-1663.2008
